Inhibiting MNK kinases promotes macrophage immunosuppressive phenotype to limit anti-tumor immunity.

被引：0
|
作者：
Pham, Thao N. D. [1 ]
Spaulding, Christina [1 ]
Shields, Mario A. [1 ]
Khalafalla, Mahmoud G. [1 ]
Principe, Daniel R. [2 ]
Bentrem, David J. [1 ]
Munshi, Hidayatullah G. [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Univ Illinois, Coll Med, Med Scientist Training Program, Chicago, IL USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-049
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [11] Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis
    Guerriero, Jennifer L.
    Sotayo, Alaba
    Ponichtera, Holly
    Pourzia, Alexandra
    Schad, Sara
    Carrasco, Ruben
    Suzan, Lazo
    Bronson, Roderick
    Letai, Anthony
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [12] Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis
    Guerriero, Jennifer
    Sotayo, Alaba
    Ponichtera, Holly
    Castrillon, Jessica
    Pourzia, Alexandra
    Schad, Sara
    Johnson, Shawn
    Carrasco, Ruben
    Lazo, Suzan
    Bronson, Roderick
    Davis, Scott
    Lobera, Mercedes
    Nolan, Michael
    Letai, Anthony
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [13] Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis
    Guerriero, Jennifer L.
    Sotayo, Alaba
    Ponichtera, Holly E.
    Castrillon, Jessica A.
    Pourzia, Alexandra L.
    Schad, Sara
    Johnson, Shawn F.
    Carrasco, Ruben D.
    Lazo, Suzan
    Bronson, Roderick T.
    Davis, Scott P.
    Lobera, Mercedes
    Nolan, Michael A.
    Letai, Anthony
    CANCER RESEARCH, 2018, 78 (04)
  • [14] A next-generation PI3Kδ/γ inhibitor, ZX-101A inhibiting solid tumor growth by enhancing anti-tumor immunity.
    Hao, Xiaolin
    Peng, Zhiyuan
    Guo, Kun
    Li, Ying-Ying
    Kong, Deming
    Yang, Jinfu
    Qin, Xiaoli
    CANCER RESEARCH, 2021, 81 (13)
  • [15] KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
    Li, Jinghan
    Shi, Daiwang
    Li, Siyi
    Shi, Xiang
    Liu, Yu
    Zhang, Yi
    Wang, Gebang
    Zhang, Chenlei
    Xia, Tian
    Piao, Hai-long
    Liu, Hong-Xu
    CELL DEATH & DISEASE, 2024, 15 (02)
  • [16] Inhibiting Yap for improved T cell activation and anti-tumor immunity
    Cheng, Nan
    Stampouloglou, Eleni
    Federico, Anthony
    Monti, Stefano
    Szeto, Gregory Lee
    Varelas, Xaralabos
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [17] Inhibition of effective anti-tumor immunity by macrophage Bcl6
    Desai, Nidhi Nitin
    Zhu, Bibo
    Son, YoungMin
    Sun, Jie
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [18] Reciprocal macrophage - T cell interactions regulate anti-tumor immunity
    Sudhakaran, Meenakshi
    Lombardi, Sofia
    Ayma, Sophie
    Krummel, Matthew F.
    Kersten, Kelly
    CANCER RESEARCH, 2024, 84 (22)
  • [19] Increased frequency and activation of CD4+ T cells enhances anti-tumor immunity.
    Brown, DM
    Woodward, JG
    Frelinger, JG
    Lord, EM
    FASEB JOURNAL, 2000, 14 (06): : A1015 - A1015
  • [20] Intra-tumor CpG-oligonucleotide injection induces protective anti-tumor T cell immunity.
    Tary-Lehmann, H
    Stern, BV
    Boehm, BO
    Lonsdorf, AS
    FASEB JOURNAL, 2002, 16 (04): : A338 - A338
12345